FDA increases scrutiny of some generic drugs

Regulation • Problem with antidepressant renews debate over knock-offs' effectiveness.
This is an archived article that was published on sltrib.com in 2012, and information in the article may be outdated. It is provided only for personal research purposes and may not be reprinted.

This article cannot be shown due to contract restrictions.